New Key Statistics Module, Z-Score and F-Score
NAS:MLAB Key Ratios
| Market Cap $ M | 735.47 |
| Enterprise Value $ M | 850.27 |
| P/E(ttm) | 156.46 |
| PE Ratio without NRI | 156.46 |
| Forward PE Ratio | 75.23 |
| Price/Book | 3.90 |
| Price/Sales | 2.96 |
| Price/Free Cash Flow | 13.97 |
| Price/Owner Earnings | 24.76 |
| Payout Ratio % | 0.76 |
| Revenue (TTM) $ M | 249.00 |
| EPS (TTM) $ | 0.84 |
| Beneish M-Score | -3.1 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -5.60 |
| EV-to-EBIT | 42.07 |
| EV-to-EBITDA | 19.70 |
| PEG | -- |
| Shares Outstanding M | 5.60 |
| Net Margin (%) | 1.92 |
| Operating Margin % | 9.00 |
| Pre-tax Margin (%) | 3.75 |
| Quick Ratio | 1.32 |
| Current Ratio | 1.79 |
| ROA % (ttm) | 1.12 |
| ROE % (ttm) | 2.63 |
| ROIC % (ttm) | 2.98 |
| Dividend Yield % | 0.49 |
| Altman Z-Score | 2.17 |
MLAB Number of Guru Trades
MLAB Volume of Guru Trades
Gurus Latest Trades with NAS:MLAB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:MLAB is held by these investors
Total 1
Mesa Laboratories Inc Insider Transactions
No Available Data
Guru Commentaries on NAS:MLAB
Conestoga Small Cap Composite
Neutral
2025 Q2
What the manager wrote
Mesa Laboratories, Inc. (MLAB) manufactures an array of instruments and products for the healthcare and other industries. The company reported better-than-expected quarterly results but saw its stock price decline on tariff concerns and its Chinese operations.
News about NAS:MLAB
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers